Encallado, Liam Aedan .
HRN: 21-14-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
07/27/2022
08/03/2022
PO
4 Ml
Q12Hrs
PCAP-A; T/C UTI; ATP
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes